rss
J Clin Pathol 2009;62:206-211 doi:10.1136/jcp.2007.049171
  • Review

Adipokines and the clinical laboratory: what to measure, when and how?

  1. M J Hill,
  2. S Kumar,
  3. P G McTernan
  1. Warwick Medical School, UK
  1. Dr P G McTernan, Warwick Medical School, UK, Unit for Diabetes & Metabolism, Clinical Science Research Institute, Clifford Bridge Road, Coventry CV2 2DX, UK; p.g.mcternan{at}warwick.ac.uk
  • Accepted 25 May 2008

Abstract

This review summarises current experimental adipokine investigations and will focus on some of the procedures and techniques that are currently important in the clinical research laboratory. The complexity of measuring adipokines is discussed and the relative success of the various applications in the transition from the laboratory to clinical diagnosis assessed. In addition, as new adipokines continue to emerge, this review will consider the direction research is taking at the cutting edge of novel adipokine discovery. Finally, how a more comprehensive understanding of the pathobiology related to adipokines may enhance innovative therapeutic strategies designed to attenuate the predicted explosion in obesity related diseases will be discussed.

Footnotes

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.